Chronic oral administration of IEM-2062 [1-(6-aminohexylamino)-1-phenylcyclohexyl dihydrochloride], which produces combined blockade of NMDA and AMPA receptors, at a dose of 3 mg/kg was found to induce a maximal anticonvulsant effect in rats with corasol kindling, producing a 100% decrease in the number of rats demonstrating corasol kindling and a 3.3-fold reduction in the mean severity of clonic-tonic kindled seizures. IEM-2062 induced significant anticonvulsant effects over a wide range of doses (1–48 mg/kg), which was 22–24 times greater than that of memantine (12–20 mg/kg) and sodium valproate (100–200 mg/kg). Sodium valproate and memantine induced significant impairment to movement activity in an open field at the doses having maximal anticonvulsant effects in rats with corasol kindling. At the same time, IEM-2062 induced impairments to movement activity only at a very high dose, 92 mg/kg, which was 30.7 times greater than the dose producing the maximal anticonvulsant effect in rats with corasol kindling. Thus, IEM-2062 decreases the severity of kindled seizures 1.7–1.9 times more effectively than sodium valproate and memantine, and has a range of therapeutic doses 22–24 times wider, as well as a 30.7 times greater level of safety than sodium valproate and memantine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
V. E. Gmiro and S. E. Serdyuk, “Combined blockade of brain AMPA and NMDA receptors eliminates clonic and clonic-tonic corasol seizures without the development of ataxia in rats,” Byull. Eksperim. Biol. Med., 145, No. 6, 675–677 (2008).
V. E. Gmiro, S. E. Serdyuk, and O. S. Veselkina, “Comparison of the pharmacological activity and safety of the glutamate blocker IEM-1913 and memantine,” Byull. Eksperim. Biol. Med., 160, No. 7, 80–83 (2015).
N. Ya. Lukomskaya, V. V. Lavrent’eva, L. A. Starshinova, et al., “Effects of blockers of glutamate receptor ionotropic channels on the development of pentylenetetrazole kindling in mice,” Ros. Fiziol. Zh., 91, No. 11, 1241–1251 (2005).
S. E. Serdyuk and V. E. Gmiro, “Stimulation of gastric mucosal afferents with adrenaline potentiates the anticonvulsant but not the sedative action of diazepam in rats,” Ros. Fiziol. Zh., 98, No. 2, 236–241 (2012).
I. M. Fedorova, V. E. Gmiro, L. G. Magazanik, and D. B. Tikhonov, “Glutamate receptor ion channels in neuromuscular junctions in Calliphora vicina fly larvae show high structural homology with the AMPA channels of vertebrates,” Zh. Evolyuts. Biokhim. Fiziol., 44, No. 6, 556–562 (2008).
T. Doi, Y. Ueda, K. Nagatomo, and L. J. Willmore, “Role of glutamate and GABA transporters in development of pentylenetetrazol-kindling,” Neurochem. Res., 34, No. 7, 1324–1331 (2009).
A. Ekonomou and F. Angelatou, “Upregulation of NMDA-receptors in hippocampus and cortex in the pentylenetetrazol-induced ‘kindling’ model of epilepsy,” Neurochem. Res., 24, No. 12, 1515–1522 (1999).
A. Ekonomou, A. L. Smith, and F. Angelatou, “Changes in AMPAreceptor binding and subunit messenger RNA expression in hippocampus and cortex in the pentylenetetrazole-induced ‘kindling’ model of epilepsy,” Brain Res. Mol. Brain Res., 95, No. 1–2, 27–35 (2001).
W. Fischer and H. Kittner, “Influence of ethanol on the pentylenetetrazol-induced kindling in rats,” Neural Transm., 105, No. 10–12, 1129–1142 (1998).
V. E. Gmiro, S. E. Serdyuk, and O. S. Veselkina, “New effective and safe glutamate antagonist compared with memantine,” J. Pharmacog. Phytochem., 4, No. 1, 77–79 (2016).
W. Löscher, “Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action,” Prog. Neurobiol., 58, No. 1, 31–59 (1999).
W. Löscher and D. Hönack, “Over-additive anticonvulsant effect of memantine and NBQX in kindled rats,” Eur. J. Pharmacol., 259, No. 2, R3-5 (1994).
W. Löscher, H. Nau, C. Marescaux, and M. Vergnes, “Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy,” Eur. J. Pharmacol., 99, No. 2–3, 211–218 (1984).
J. Mehla, K. H. Reeta, P. Gupta, and Y. K. Gupta, “Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model,” Life Sci., 87, No. 19–22, 596–603 (2010).
K. Morimoto, M. Fahnestock, and R. J. Racine, “Kindling and status epilepticus models of epilepsy: rewiring the brain,” Prog. Neurobiol., 73, No. 1, 1–60 (2004).
Y. Ohno, S. Ishihara, R. Terada, et al., “Antiepileptogenic and anticonvulsive actions of levetiracetam in a pentylenetetrazole kindling model,” Epilepsy Res., 89, No. 2–3, 360–364 (2010).
C. G. Parsons, G. Quack, I. Bresink, et al., “Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA-receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo,” Neuropharmacology, 34, No. 10, 1239–1258 (1995).
N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro, and N. Y. Lukomskaya, “The ability of new non-competitive glutamate receptor blockers to weaken motor disorders in animals,” Neurosci. Behav. Physiol., 33, No. 3, 273–278 (2003).
P. Tirassa, N. Costa, and L. Aloe, “CCK-8 prevents the development of kindling and regulates the GABA and NPY expression in the hippocampus of pentylenetetrazole (PTZ)-treated adult rats,” Neuropharmacology, 48, No. 5, 732–742 (2005).
R. D. Whitlow, A. Sacher, D. D. Loo, et al., “The anticonvulsant valproate increases the turnover rate of gamma-aminobutyric acid transporters,” Biol. Chem., 278, No. 20, 17,716–17,726 (2003).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Rossiiskii Fiziologicheskii Zhurnal imeni I. M. Sechenova, Vol. 103, No. 3, pp. 299–306, March, 2017.
Rights and permissions
About this article
Cite this article
Gmiro, V.E., Serdyuk, S.E. & Veselkina, O.S. Comparison of the Chronic Anticonvulsant Activity and Safety of IEM-2062, Sodium Valproate, and Memantine in a Corasol Kindling Model in Rats. Neurosci Behav Physi 48, 729–733 (2018). https://doi.org/10.1007/s11055-018-0623-3
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-018-0623-3